Pharmaceutical markets of the CIS countries: results of July 2025 (according to IQVIA)

According to IQVIA, the pharmaceutical markets of the CIS countries demonstrate noticeable differences in volume, dynamics and structure. Kazakhstan and Uzbekistan remain the leaders of the region, accounting for more than half of the total market. At the same time, a number of countries maintain limited volumes and high dependence on imports.

🇰🇿 Kazakhstan

The market volume amounted to USD 2.46 billion (+12% compared to 2024). The bulk of sales comes from the retail segment (58%), hospital purchases account for 42%. The share of prescription drugs is 69%. Kazakhstan is the largest market in the region and demonstrates stable growth.

🇺🇿 Uzbekistan

The market is estimated at 2.03 billion USD (+28% compared to 2024). Retail accounts for 72% of sales, budget purchases - 28%. The share of prescription drugs is 68%. Uzbekistan shows the highest growth rates in the region and ranks second in terms of volume.

🇧🇾 Belarus

The market volume reached 1.39 billion USD (+22%). Retail segment - 69%, hospital - 31%. Prescription drugs account for 72%. Belarus is distinguished by a significant presence of national manufacturers, which form a noticeable share in the sales structure.

🇦🇿 Azerbaijan

The market is 670 million USD (+8%). All sales are retail, the share of prescription drugs is 67%. The market is completely dependent on imports.

🇦🇲 Armenia

The market size is 376 million USD (+15%). All sales are generated in retail, prescription drugs account for 59%. A small but growing market.

🇰🇬 Kyrgyzstan

The market is estimated at 315 million USD (+15%). Sales are almost entirely retail (95%), the hospital segment is only 5%. The share of prescription drugs is 58%. The growth is mainly due to private demand.

🇹🇯 Tajikistan

The pharmaceutical market amounted to USD 524 million, but showed a decline: -2% in monetary terms and -20% in packages. Sales are entirely retail, the share of prescription drugs is 66%. The only CIS country with negative dynamics.

Final observations:

• Kazakhstan and Uzbekistan are the largest markets in the region with high growth dynamics.

• Belarus is developing steadily, relying on national production.

• Azerbaijan and Armenia are entirely retail markets with moderate growth rates.

• Kyrgyzstan is growing in retail with weak development of the hospital segment.

• Tajikistan stands out with negative dynamics, which reflects the instability of the domestic market.

Thus, the CIS pharmaceutical markets maintain the general growth trend.

Read more: Facts from IQVIA — Eurasia July 2025 (https://drive.google.com/file/d/1025OuslRya050m96PXLhsy9gOR6f2boj/view?usp=sharing)